Evoq Remedies Limited (BOM:543500)

Evoq Remedies Revenue

In the fiscal year ending March 31, 2026, Evoq Remedies had annual revenue of 267.57M INR with 88.81% growth. Evoq Remedies had revenue of 265.68M in the half year ending September 30, 2025, with 580.78% growth.

• Revenue: 267.57M
• Revenue Growth: +88.81%
• P/S Ratio: 0.30
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 79.93M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	267.57M	125.86M	88.81%
Mar 31, 2025	141.71M	78.62M	124.62%
Mar 31, 2024	63.09M	-201.04M	-76.11%
Mar 31, 2023	264.13M	96.29M	57.38%
Mar 31, 2022	167.83M	67.58M	67.42%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 2, 2026

Data Sources Report a data error